{
    "title": "109_s2115",
    "content": "The Act is known as the \"Morris K. Udall Parkinson's Disease Research Act Amendments of 2005\". It amends the Morris K. Udall Parkinson's Disease Research Act of 1997. The Morris K. Udall Parkinson's Disease Research Act of 1977 is amended to expand federal investment in Parkinson's research and strengthen coordination among NIH institutes. The Public Health Service Act is also amended to require a coordinating conference every 2 years. The Morris K. Udall Parkinson's Disease Research Act of 1977 is amended to increase federal funding for Parkinson's research and improve coordination among NIH institutes. A coordinating conference is required every 2 years to assess funded research and identify opportunities for better treatments and a cure for the disease. The Director will report to Congress on the progress of research coordination. The plan for Parkinson's disease research funding focuses on better treatments and a cure, utilizing the Udall Center program for translational research. It includes a budget and implementation strategy for special initiatives. The plan for Parkinson's disease research funding includes special initiatives like Requests for Applications and Program Announcements with set-asides. Results are to be reported back to Congress, with submissions and outcomes to be provided on an annual basis. Funding will be ensured by the Secretary. The Secretary will ensure adequate funding for activities described in the investment plan. An additional center will be funded to serve as a coordinating center for interdisciplinary efforts. The Director of NIH will establish a review process for grant applications, emphasizing the clinical, coordination, and multidisciplinary components of the applicants. Grants will be awarded instead of establishing a grant program. The Director of NIH will conduct an investigation and submit a report to Congress on the incidence of Parkinson's disease, including related environmental factors. Authorization of appropriations is provided for carrying out this section. Authorized appropriations for research on Parkinson's disease for fiscal years 2007 through 2012."
}